I think the other players would be provinces that, at the current time, are effectively data stewards as it relates to administrative data records around pharmaceutical use and other health care services. They're going to be a key player in terms of ongoing, active post-market surveillance and what is sometimes referred to as data mining.
Key initiatives to be taken I think are an investment in personnel and infrastructure necessary to engage in this. I think it is also necessary to have a secretariat or advisory council that can actually set priorities and ensure that the research being done is in fact of value to the regulatory frame and these other partners.